Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87105693 | 8710569 | 3 | F | 20120728 | 20160901 | 20120807 | 20160913 | PER | US-PFIZER INC-2012188358 | PFIZER | 69.00 | YR | M | Y | 106.00000 | KG | 20160913 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87105693 | 8710569 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC | 21938 | 50 | MG | CAPSULE, HARD | ||||||||
| 87105693 | 8710569 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 37.5 MG, CYCLIC | 193TV | 21938 | 37.5 | MG | CAPSULE, HARD | |||||||
| 87105693 | 8710569 | 3 | SS | SUTENT | SUNITINIB MALATE | 1 | Oral | 37.5 MG, CYCLIC (12.5MG- 3CAPS BY MOUTH DAILY FOR 14 DAYS ON AND 7 DAYS OFF) | 21938 | 37.5 | MG | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 87105693 | 8710569 | 1 | Renal cell carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 87105693 | 8710569 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 87105693 | 8710569 | Diarrhoea | |
| 87105693 | 8710569 | Myocardial infarction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 87105693 | 8710569 | 3 | 20110114 | 0 |